Haw Par (H02) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
14 Aug, 2026Executive summary
Revenue for the half year ended 30 June 2026 declined 8.2% year-over-year to $115.9m, reflecting softer consumer sentiment and a high comparative base from advanced orders in 2025.
Profit for the period fell 25.2% to $107.9m, with earnings per share at 48.7 cents, down from 65.1 cents a year earlier.
Other income dropped 29.9% due to lower dividend and interest income from strategic investments.
Financial highlights
Gross profit decreased 9.6% to $64.6m, with gross margin slightly lower at 55.7% versus 56.5% last year.
Operating profit before tax was $115.2m, down 24.2% year-over-year.
Cash and bank balances declined 15.5% to $669.1m, mainly due to increased investments and dividend payments.
Strategic and long-term investments rose 12.0% to $3.8b, driven by higher market valuations.
Outlook and guidance
Persistent inflation and geopolitical conflicts are expected to continue softening consumer demand and create a challenging operating environment.
Emphasis will be placed on disciplined cost management and operational resilience in the coming periods.
Latest events from Haw Par
- Net profit rose 16.3% to S$265.5m as cost controls offset weaker Healthcare sales.H02
H2 2025 - Net profit surged 17.1% to S$122.0m on higher revenue and investment income, despite margin pressure.H02
H1 2024 - Revenue and net profit rose, but margins narrowed amid higher costs and market volatility.H02
H2 2024 - Net profit rose 18.2% to S$144.1m on higher revenue and investment income.H02
H1 2025